Publications
16
Citations
219
Est. group size
—
Recurring co-author estimate
Active years
15
Publishing since 2012
Eric Hawley conducts medical research focused on the molecular biology of tumors and immune-related conditions, including nerve-sheath tumors (schwannomas and neurofibromatosis) and childhood cancers such as neuroblastoma. Much of the work investigates cell-signaling pathways (such as RAS/MAPK and Hippo signaling) to identify potential therapeutic targets. Some publications also address immune and inflammatory diseases like rheumatoid arthritis and immune deficiencies.
Publication activity peaked around 2019-2020 and has since slowed to roughly one paper per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Germline <i>MRAS</i> Variant in an Infant With Bilateral Adrenal Neuroblastoma
Pediatric Blood & Cancer · 2026
- JAK Inhibition in STAT1 Gain-of-Function-Associated Histoplasmosis and HLH
Journal of Clinical Immunology · 2025
- Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Arthritis Research & Therapy · 2020
- Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling
JCI Insight · 2020
- An Investigation of Molecular Pathways to Aid in Therapeutic Development for Neurofibromatosis Type 2
IUScholarWorks (Indiana University) · 2019
- Human Molecular Genetics×2
- Journal of Biological Chemistry×2
- PMC×2
- PLoS ONE×1
- Arthritis Research & Therapy×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile